U.S. medicine last week witnessed the strange spectacle of two large, well-meaning foundations fighting over which one has the franchise to help the sick in a large and serious disease field. After 20 years of vigorous life, during which it raised $560 million (virtually all from the March of Dimes), the National Foundation for Infantile Paralysis announced last week a change of name and a raising of its sights against far commoner ills than polio. Henceforth to be called simply the National Foundation, the aggressive organization that spent $34 million on the research that produced (among other gains) the Salk vaccine...
To continue reading:
or
Log-In
